TransCode Therapeutics, Inc. Common Stock (RNAZ) Stock Price
TransCode Therapeutics, Inc. Common Stock (NASDAQ: RNAZ) last traded at $2.87, down 3.37% on the session. The quote above updates while this page is open; the figures below are drawn from TransCode Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
TransCode Therapeutics, Inc. Common Stock (RNAZ) company overview
TransCode Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker RNAZ. Its market capitalisation is $48.59 million.
RNAZ valuation
Valuation measures for TransCode Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
Market cap
$48.59M
Enterprise value
$52.86M
Beta
0.74
RNAZ financials
Trailing-twelve-month figures tagged in TransCode Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
Net income (TTM)
-$42.83M
Cash
$8.38M
RNAZ trading statistics
Range and volume for RNAZ over the past 52 weeks.
52-week high
$20.99
52-week low
$2.87
Volume
38.4K
Average volume
66.8K
Previous close
$2.97
TransCode Therapeutics, Inc. Common Stock (RNAZ) FAQs
What is the RNAZ stock price today?
TransCode Therapeutics, Inc. Common Stock (RNAZ) last traded at $2.87, down 3.37% on the session. FurlPay quotes RNAZ from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is RNAZ listed on?
TransCode Therapeutics, Inc. Common Stock is listed on NASDAQ under the ticker symbol RNAZ.
What is TransCode Therapeutics, Inc. Common Stock's market cap?
TransCode Therapeutics, Inc. Common Stock has a market capitalisation of $48.59 million, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is RNAZ's 52-week range?
Over the past 52 weeks RNAZ has traded between $2.87 and $20.99.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0001829635), period ending 2026-06-30.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.
RNAZ Stock Price & Quote | TransCode Therapeutics, Inc. Common Stock | FurlPay